{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:38:49Z","timestamp":1793248729768,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T00:00:00Z","timestamp":1332460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00270-012-0369-1","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T12:41:25Z","timestamp":1332506485000},"page":"204-212","source":"Crossref","is-referenced-by-count":15,"title":["Toxicity of Doxorubicin on Pig Liver After Chemoembolization with Doxorubicin-loaded Microspheres: A Pilot DNA-microarrays and Histology Study"],"prefix":"10.1007","volume":"36","author":[{"given":"Valentin","family":"Verret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Namur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00efda Homayra","family":"Ghegediban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Wassef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Moine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Bonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Pelage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,23]]},"reference":[{"key":"369_CR1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","volume":"37","author":"JM Llovet","year":"2003","unstructured":"Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429\u2013442","journal-title":"Hepatology"},{"key":"369_CR2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1634\/theoncologist.8-5-425","volume":"8","author":"K Stuart","year":"2003","unstructured":"Stuart K (2003) Chemoembolization in the management of liver tumors. Oncologist 8:425\u2013437","journal-title":"Oncologist"},{"key":"369_CR3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","volume":"33","author":"J Lammer","year":"2010","unstructured":"Lammer J, Malagari K, Vogl T et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Interv Radiol 33:41\u201352","journal-title":"Cardiovasc Interv Radiol"},{"key":"369_CR4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00270-007-9226-z","volume":"31","author":"K Malagari","year":"2008","unstructured":"Malagari K, Chatzimichael K, Alexopoulou E et al (2008) Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Interv Radiol 31:269\u2013280","journal-title":"Cardiovasc Interv Radiol"},{"key":"369_CR5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/01.RVI.0000228416.21560.7F","volume":"17","author":"AL Lewis","year":"2006","unstructured":"Lewis AL, Taylor RR, Hall B et al (2006) Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol 17:1335\u20131343","journal-title":"J Vasc Interv Radiol"},{"key":"369_CR6","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1158\/1078-0432.CCR-05-2225","volume":"12","author":"K Hong","year":"2006","unstructured":"Hong K, Khwaja A, Liapi E et al (2006) New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res 12:2563\u20132567","journal-title":"Clin Cancer Res"},{"key":"369_CR7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jvir.2009.10.026","volume":"21","author":"J Namur","year":"2010","unstructured":"Namur J, Wassef M, Millot JM et al (2010) Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model. J Vasc Interv Radiol 21:259\u2013267","journal-title":"J Vasc Interv Radiol"},{"key":"369_CR8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","volume":"46","author":"M Varela","year":"2007","unstructured":"Varela M, Real MI, Burrel M et al (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46:474\u2013481","journal-title":"J Hepatol"},{"key":"369_CR9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cgh.2007.04.021","volume":"5","author":"RT Poon","year":"2007","unstructured":"Poon RT, Tso WK, Pang RW et al (2007) A phase I\/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol 5:1100\u20131108","journal-title":"Clin Gastroenterol Hepatol"},{"key":"369_CR10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000329602","volume":"34","author":"H Malenstein van","year":"2011","unstructured":"van Malenstein H, Maleux G, Vandecaveye V et al (2011) A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma. Onkologie 34:368\u2013376","journal-title":"Onkologie"},{"key":"369_CR11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1477-2574.2009.00071.x","volume":"11","author":"S Carter","year":"2009","unstructured":"Carter S, Martin Ii RC (2009) Drug-eluting bead therapy in primary and metastatic disease of the liver. HPB (Oxford) 11:541\u2013550","journal-title":"HPB (Oxford)"},{"key":"369_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00270-010-0012-y","volume":"34","author":"E Liapi","year":"2011","unstructured":"Liapi E, Geschwind JF (2011) Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization? Cardiovasc Interv Radiol 34:37\u201349","journal-title":"Cardiovasc Interv Radiol"},{"issue":"4","key":"369_CR13","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s00270-010-0044-3","volume":"34","author":"K Malagari","year":"2011","unstructured":"Malagari K, Pomoni M, Spyridopoulos TN et al (2011) Safety profile of sequential transcatheter chemoembolization with DC Bead\u2122: results of 237 hepatocellular carcinoma (HCC) patients. Cardiovasc Interv Radiol 34(4):774\u2013785","journal-title":"Cardiovasc Interv Radiol"},{"key":"369_CR14","first-page":"364","volume":"131","author":"RT Chlebowski","year":"1979","unstructured":"Chlebowski RT (1979) Adriamycin (doxorubicin) cardiotoxicity: a review. West J Med 131:364\u2013368","journal-title":"West J Med"},{"key":"369_CR15","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S1051-0443(07)61299-8","volume":"11","author":"JF Geschwind","year":"2000","unstructured":"Geschwind JF, Artemov D, Abraham S et al (2000) Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol 11:1245\u20131255","journal-title":"J Vasc Interv Radiol"},{"key":"369_CR16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/138920008783884696","volume":"9","author":"VS Gomase","year":"2008","unstructured":"Gomase VS, Tagore S (2008) Toxicogenomics. Curr Drug Metab 9:250\u2013254","journal-title":"Curr Drug Metab"},{"key":"369_CR17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxlet.2008.09.017","volume":"186","author":"EA Blomme","year":"2009","unstructured":"Blomme EA, Yang Y, Waring JF (2009) Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development. Toxicol Lett 186:22\u201331","journal-title":"Toxicol Lett"},{"key":"369_CR18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.biomaterials.2010.09.001","volume":"32","author":"V Verret","year":"2011","unstructured":"Verret V, Wassef M, Pelage JP et al (2011) Influence of degradation on inflammatory profile of polyphosphazene coated PMMA and trisacryl gelatin microspheres in a sheep uterine artery embolization model. Biomaterials 32:339\u2013351","journal-title":"Biomaterials"},{"key":"369_CR19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3171\/JNS-07\/07\/0109","volume":"107","author":"I Yuki","year":"2007","unstructured":"Yuki I, Lee D, Murayama Y et al (2007) Thrombus organization and healing in an experimental aneurysm model. Part II. The effect of various types of bioactive bioabsorbable polymeric coils. J Neurosurg 107:109\u2013120","journal-title":"J Neurosurg"},{"key":"369_CR20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1586\/erd.09.20","volume":"6","author":"AL Lewis","year":"2009","unstructured":"Lewis AL (2009) DC Bead: a major development in the toolbox for the interventional oncologist. Expert Rev Med Devices 6:389\u2013400","journal-title":"Expert Rev Med Devices"},{"key":"369_CR21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.RVI.0000195323.46152.B3","volume":"17","author":"AL Lewis","year":"2006","unstructured":"Lewis AL, Gonzalez MV, Lloyd AW et al (2006) DC Bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17:335\u2013342","journal-title":"J Vasc Interv Radiol"},{"key":"369_CR22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2199-7-3","volume":"7","author":"A Schroeder","year":"2006","unstructured":"Schroeder A, Mueller O, Stocker S et al (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7:3","journal-title":"BMC Mol Biol"},{"key":"369_CR23","unstructured":"Dembele D, Jost B, Thibault-Carpentier C et al (2007) Zoe: a user friendly tool for filtering microarray data. In: Proceedings JOBIM Marseille, France"},{"key":"369_CR24","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1126\/science.1177321","volume":"325","author":"D Ahel","year":"2009","unstructured":"Ahel D, Horejsi Z, Wiechens N et al (2009) Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science 325:1240\u20131243","journal-title":"Science"},{"key":"369_CR25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2010.05.020","volume":"298","author":"EU Jung","year":"2010","unstructured":"Jung EU, Yoon JH, Lee YJ et al (2010) Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells. Cancer Lett 298:9\u201315","journal-title":"Cancer Lett"},{"key":"369_CR26","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1158\/0008-5472.CAN-08-2545","volume":"69","author":"MJ Perugorria","year":"2009","unstructured":"Perugorria MJ, Castillo J, Latasa MU et al (2009) Wilms\u2019 tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy. Cancer Res 69:1358\u20131367","journal-title":"Cancer Res"},{"key":"369_CR27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm.2090","volume":"16","author":"Y Li","year":"2010","unstructured":"Li Y, Zou L, Li Q et al (2010) Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med 16:214\u2013218","journal-title":"Nat Med"},{"key":"369_CR28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/156800908783769337","volume":"8","author":"E Meulmeester","year":"2008","unstructured":"Meulmeester E, Jochemsen AG (2008) p53: a guide to apoptosis. Curr Cancer Drug Targets 8:87\u201397","journal-title":"Curr Cancer Drug Targets"},{"key":"369_CR29","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1182\/blood-2005-04-1629","volume":"107","author":"O Margalit","year":"2006","unstructured":"Margalit O, Amram H, Amariglio N et al (2006) BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma. Blood 107:1599\u20131607","journal-title":"Blood"},{"key":"369_CR30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgm200","volume":"29","author":"TP Ellen","year":"2008","unstructured":"Ellen TP, Ke Q, Zhang P et al (2008) NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis 29:2\u20138","journal-title":"Carcinogenesis"},{"key":"369_CR31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/jjco\/hyp194","volume":"40","author":"H Sugiyama","year":"2010","unstructured":"Sugiyama H (2010) WT1 (Wilms\u2019 tumor gene 1): biology and cancer immunotherapy. Jpn J Clin Oncol 40:377\u2013387","journal-title":"Jpn J Clin Oncol"},{"key":"369_CR32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.ejhg.5200795","volume":"10","author":"R Saffroy","year":"2002","unstructured":"Saffroy R, Riou P, Soler G et al (2002) Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma. Eur J Hum Genet 10:239\u2013244","journal-title":"Eur J Hum Genet"},{"key":"369_CR33","volume-title":"Integrated pharmacology","author":"C Page","year":"1997","unstructured":"Page C, Curtis M, Sutter M et al (1997) Integrated pharmacology. DeBoeck Universit\u00e9, Brussels"},{"key":"369_CR34","first-page":"23","volume":"40","author":"JM Schroder","year":"1992","unstructured":"Schroder JM (1992) The neutrophil-activating peptide-1\/interleukin-8, a novel neutrophil chemotactic cytokine. Arch Immunol Ther Exp (Warsz) 40:23\u201331","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"369_CR35","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/labinvest.3780456","volume":"82","author":"K Uchio","year":"2002","unstructured":"Uchio K, Tuchweber B, Manabe N et al (2002) Cellular retinol-binding protein-1 expression and modulation during in vivo and in vitro myofibroblastic differentiation of rat hepatic stellate cells and portal fibroblasts. Lab Invest 82:619\u2013628","journal-title":"Lab Invest"},{"key":"369_CR36","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1128\/MCB.20.10.3742-3751.2000","volume":"20","author":"EC Hsiao","year":"2000","unstructured":"Hsiao EC, Koniaris LG, Zimmers-Koniaris T et al (2000) Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol 20:3742\u20133751","journal-title":"Mol Cell Biol"},{"key":"369_CR37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1215\/S1152851704001115","volume":"7","author":"B Kaur","year":"2005","unstructured":"Kaur B, Khwaja FW, Severson EA et al (2005) Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 7:134\u2013153","journal-title":"Neuro Oncol"},{"key":"369_CR38","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1074\/jbc.271.2.736","volume":"271","author":"T Cohen","year":"1996","unstructured":"Cohen T, Nahari D, Cerem LW et al (1996) Interleukin-6 induces the expression of vascular endothelial growth factor. J Biol Chem 271:736\u2013741","journal-title":"J Biol Chem"},{"key":"369_CR39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1245\/ASO.2006.03.096","volume":"13","author":"O Kollmar","year":"2006","unstructured":"Kollmar O, Scheuer C, Menger MD et al (2006) Macrophage inflammatory protein-2 promotes angiogenesis, cell migration, and tumor growth in hepatic metastasis. Ann Surg Oncol 13:263\u2013275","journal-title":"Ann Surg Oncol"},{"key":"369_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.68.1.1","volume":"68","author":"JA Belperio","year":"2000","unstructured":"Belperio JA, Keane MP, Arenberg DA et al (2000) CXC chemokines in angiogenesis. J Leukoc Biol 68:1\u20138","journal-title":"J Leukoc Biol"},{"key":"369_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1329.002","volume":"1030","author":"S Delhalle","year":"2004","unstructured":"Delhalle S, Blasius R, Dicato M et al (2004) A beginner\u2019s guide to NF-kappaB signaling pathways. Ann N Y Acad Sci 1030:1\u201313","journal-title":"Ann N Y Acad Sci"},{"key":"369_CR42","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/sj.onc.1206223","volume":"22","author":"H Li","year":"2003","unstructured":"Li H, Fredriksson L, Li X et al (2003) PDGF-D is a potent transforming and angiogenic growth factor. Oncogene 22:1501\u20131510","journal-title":"Oncogene"},{"key":"369_CR43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11033-007-9171-6","volume":"36","author":"N Chung","year":"2009","unstructured":"Chung N, Jee BK, Chae SW et al (2009) HOX gene analysis of endothelial cell differentiation in human bone marrow-derived mesenchymal stem cells. Mol Biol Rep 36:227\u2013235","journal-title":"Mol Biol Rep"},{"key":"369_CR44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1128\/MCB.22.1.12-22.2002","volume":"22","author":"A Alfranca","year":"2002","unstructured":"Alfranca A, Gutierrez MD, Vara A et al (2002) c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription. Mol Cell Biol 22:12\u201322","journal-title":"Mol Cell Biol"},{"key":"369_CR45","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1078-0432.CCR-08-1945","volume":"15","author":"Y Song","year":"2009","unstructured":"Song Y, Wu J, Oyesanya RA et al (2009) Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism. Clin Cancer Res 15:492\u2013501","journal-title":"Clin Cancer Res"},{"key":"369_CR46","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1101\/gad.1134603","volume":"17","author":"I Adini","year":"2003","unstructured":"Adini I, Rabinovitz I, Sun JF et al (2003) RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development. Genes Dev 17:2721\u20132732","journal-title":"Genes Dev"},{"key":"369_CR47","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jvir.2009.06.028","volume":"20","author":"S Sahara","year":"2009","unstructured":"Sahara S, Tanihata H, Sato M et al (2009) Effects of hepatic artery chemoembolization using cisplatin-lipiodol suspension with gelatin sponge particles on swine liver. J Vasc Interv Radiol 20:1359\u20131364","journal-title":"J Vasc Interv Radiol"},{"key":"369_CR48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0046-8177(88)80204-1","volume":"19","author":"JF Tomashefski Jr","year":"1988","unstructured":"Tomashefski JF Jr, Cohen AM, Doershuk CF (1988) Long-term histopathologic follow-up of bronchial arteries after therapeutic embolization with polyvinyl alcohol (Ivalon) in patients with cystic fibrosis. Hum Pathol 19:555\u2013561","journal-title":"Hum Pathol"},{"key":"369_CR49","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.fertnstert.2007.12.015","volume":"91","author":"A Laurent","year":"2009","unstructured":"Laurent A, Wassef M, Namur J et al (2009) Recanalization and particle exclusion after embolization of uterine arteries in sheep: a long-term study. Fertil Steril 91:884\u2013892","journal-title":"Fertil Steril"},{"key":"369_CR50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.RVI.0000052296.26939.4c","volume":"14","author":"GP Siskin","year":"2003","unstructured":"Siskin GP, Dowling K, Virmani R et al (2003) Pathologic evaluation of a spherical polyvinyl alcohol embolic agent in a porcine renal model. J Vasc Interv Radiol 14:89\u201398","journal-title":"J Vasc Interv Radiol"},{"key":"369_CR51","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/01.pas.0000159776.77912.ce","volume":"29","author":"W Weichert","year":"2005","unstructured":"Weichert W, Denkert C, Gauruder-Burmester A et al (2005) Uterine arterial embolization with tris-acryl gelatin microspheres: a histopathologic evaluation. Am J Surg Pathol 29:955\u2013961","journal-title":"Am J Surg Pathol"},{"key":"369_CR52","first-page":"2891","volume":"36","author":"RL Momparler","year":"1976","unstructured":"Momparler RL, Karon M, Siegel SE et al (1976) Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells. Cancer Res 36:2891\u20132895","journal-title":"Cancer Res"},{"key":"369_CR53","volume-title":"Pharmacology","author":"H Rang","year":"2003","unstructured":"Rang H, Dale M, Ritter J et al (2003) Pharmacology. Churchill Livingstone, London"},{"key":"369_CR54","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ijc.1490","volume":"94","author":"M Yoshida","year":"2001","unstructured":"Yoshida M, Suzuki T, Komiya T et al (2001) Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin. Int J Cancer 94:432\u2013437","journal-title":"Int J Cancer"},{"key":"369_CR55","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0006-2952(90)90705-P","volume":"40","author":"SV Singh","year":"1990","unstructured":"Singh SV, Iqbal J, Krishan A (1990) Cytochrome P450 reductase, antioxidant enzymes and cellular resistance to doxorubicin. Biochem Pharmacol 40:385\u2013387","journal-title":"Biochem Pharmacol"},{"key":"369_CR56","first-page":"1044","volume":"55","author":"I Ishii","year":"1997","unstructured":"Ishii I, Kitada M (1997) Multidrug-resistance by induction of inactivation for anti-cancer drugs. Nippon Rinsho 55:1044\u20131049","journal-title":"Nippon Rinsho"},{"key":"369_CR57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.etp.2005.02.005","volume":"57","author":"S Sehata","year":"2005","unstructured":"Sehata S, Kiyosawa N, Atsumi F et al (2005) Microarray analysis of T-2 toxin-induced liver, placenta and fetal liver lesions in pregnant rats. Exp Toxicol Pathol 57:15\u201328","journal-title":"Exp Toxicol Pathol"},{"key":"369_CR58","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cvr\/cvq049","volume":"86","author":"AG Arroyo","year":"2010","unstructured":"Arroyo AG, Iruela-Arispe ML (2010) Extracellular matrix, inflammation, and the angiogenic response. Cardiovasc Res 86:226\u2013235","journal-title":"Cardiovasc Res"},{"key":"369_CR59","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655\u20131669","journal-title":"Gastroenterology"},{"key":"369_CR60","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3171\/jns.2002.97.3.0658","volume":"97","author":"RL Jensen","year":"2002","unstructured":"Jensen RL, Soleau S, Bhayani MK et al (2002) Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas. J Neurosurg 97:658\u2013667","journal-title":"J Neurosurg"},{"key":"369_CR61","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1227\/01.NEU.0000134556.20116.30","volume":"55","author":"U Sure","year":"2004","unstructured":"Sure U, Battenberg E, Dempfle A et al (2004) Hypoxia-inducible factor and vascular endothelial growth factor are expressed more frequently in embolized than in nonembolized cerebral arteriovenous malformations. Neurosurgery 55:663\u2013669 discussion 669-670","journal-title":"Neurosurgery"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-012-0369-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00270-012-0369-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-012-0369-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T10:55:26Z","timestamp":1687344926000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00270-012-0369-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,23]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["369"],"URL":"https:\/\/doi.org\/10.1007\/s00270-012-0369-1","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,23]]}}}